Login / Signup

Acute myeloid leukemia as an adverse event in a patient treated with a poly(ADP-ribose) polymerase (PARP) inhibitor.

Sandrine GirardCamille Lours
Published in: American journal of hematology (2023)
Keyphrases
  • acute myeloid leukemia
  • dna damage
  • case report
  • dna repair
  • allogeneic hematopoietic stem cell transplantation
  • emergency department
  • oxidative stress
  • adverse drug